S350-0825 Screening compound: 2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-propylacetamide

S350-0825 Screening compound: 2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-propylacetamide
S350-0825 Screening compound: 2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-propylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S350-0825
2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-propylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S350-0825

Molecular Formula

C19H23N3O5 (C19 H23 N3 O5)

Compound Name

2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-propylacetamide

IUPAC name

2-[4-(2-ethoxyphenyl)-25-dioxo-1H2H3H4H5H7H-furo[34-d]pyrimidin-1-yl]-N-propylacetamide

SMILES

CCCNC(CN(C(CO1)=C(C(c(cccc2)c2OCC)N2)C1=O)C2=O)=O

InChI

InChI=1S/C19H23N3O5/c1-3-9-20-15(23)10-22-13-11-27-18(24)16(13)17(21-19(22)25)12-7-5-6-8-14(12)26-4-2/h5-8,17H,3-4,9-11H2,1-2H3,(H,20,23)(H,21,25)/t17-/m0/s1

InChI Key

ALZHFSWVCWCOPS-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD29000417

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

373.41

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.585

Distribution Coefficient, logD

1.584

Water Solubility, LogSw

-2.20

Polar Surface Area

82.186

Acid Dissociation Constant (pKa)

10.03

Base Dissociation Constant (pKb)

0.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.10

S350-0825 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Antibacterial Compounds Library (13827 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
Therapeutical areas:
  • Infections
  • Immune system
  • animal
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S350-0825 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S350-0825?
Check Price and Availability of S350-0825, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S350-0825 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S350-0825
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S350-0825
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S350-0825 available by request